EUVIMEDEUVIMED entdecken
Open Access

N -acetylcysteine and cysteamine bitartrate prevent azide-induced neuromuscular decompensation by restoring glutathione balance in two novel surf1 −/− zebrafish deletion models of Leigh syndrome

Suraiya Haroon iD, Heeyong Yoon, Christoph Seiler iD, Bruce Osei-Frimpong, Jie He, Rohini M Nair, Neal D Mathew, Leonard Burg iD, Melis Kose, Chavali R M Venkata, Vernon E Anderson iD, Eiko Nakamaru-Ogiso iD und 1 weitere

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddad031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Suraiya Haroon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia,…. Hauptthemen laut MEDLINE: Leigh Disease, Cytochrome-c Oxidase Deficiency. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SURF1 deficiency (OMIM # 220110) causes Leigh syndrome (LS, OMIM # 256000), a mitochondrial disorder typified by stress-induced metabolic strokes, neurodevelopmental regression and progressive multisystem dysfunction. Here, we describe two novel surf1−/− zebrafish knockout models generated by CRISPR/Cas9 technology. While gross larval morphology, fertility, and survival into adulthood appeared unaffected, surf1−/− mutants manifested adult-onset ocular anomalies and decreased swimming activity, as well as classical biochemical hallmarks of human SURF1 disease, including reduced complex IV expression and enzymatic activity and increased tissue lactate. surf1−/− larvae also demonstrated oxidative stress and stressor hypersensitivity to the complex IV inhibitor, azide, which exacerbated their complex IV deficiency, reduced supercomplex formation, and induced acute neurodegeneration typical of LS including brain death, impaired neuromuscular responses, reduced swimming activity, and absent heartrate. Remarkably, prophylactic treatment of surf1−/− larvae with either cysteamine bitartrate or N-acetylcysteine, but not other antioxidants, significantly improved animal resiliency to stressor-induced brain death, swimming and neuromuscular dysfunction, and loss of heartbeat. Mechanistic analyses demonstrated cysteamine bitartrate pretreatment did not improve complex IV deficiency, ATP deficiency, or increased tissue lactate but did reduce oxidative stress and restore glutathione balance in surf1−/− animals. Overall, two novel surf1−/− zebrafish models recapitulate the gross neurodegenerative and biochemical hallmarks of LS, including azide stressor hypersensitivity that was associated with glutathione deficiency and ameliorated by cysteamine bitartrate or N-acetylcysteine therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leigh DiseaseCytochrome-c Oxidase DeficiencyAnimalsAdultHumansZebrafishAcetylcysteineCysteamineAzidesBrain DeathMembrane ProteinsMitochondrial ProteinsElectron Transport Complex IVGlutathioneLactates

Substanzen

AcetylcysteineCysteamineAzidesMembrane ProteinsMitochondrial ProteinsElectron Transport Complex IVGlutathioneLactates

Autor:innen und Institutionen

  • Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Zebrafish Core, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Scheie Eye Center, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

ORCID-Profile: Suraiya Haroon, Christoph Seiler, Leonard Burg, Vernon E Anderson, Eiko Nakamaru-Ogiso, Marni J Falk

Förderung

  • NICHD NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • BrightFocus Foundation
  • Research to Prevent Blindness
  • The Paul and Evanina Bell Mackall Foundation Trust
  • Lisa Dean Moseley Foundation
  • National Institutes of Health

Zitieren

APA

Haroon, S., Yoon, H., Seiler, C., Osei-Frimpong, B., He, J., Nair, R. M., Mathew, N. D., Burg, L., Kose, M., Venkata, C. R. M., Anderson, V. E., Nakamaru-Ogiso, E., & Falk, M. J. (2023). N -acetylcysteine and cysteamine bitartrate prevent azide-induced neuromuscular decompensation by restoring glutathione balance in two novel surf1 −/− zebrafish deletion models of Leigh syndrome. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad031

Vancouver

Haroon S, Yoon H, Seiler C, Osei-Frimpong B, He J, Nair RM, et al. N -acetylcysteine and cysteamine bitartrate prevent azide-induced neuromuscular decompensation by restoring glutathione balance in two novel surf1 −/− zebrafish deletion models of Leigh syndrome. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad031

BibTeX
@article{Haroon2023,
  author = {Haroon, Suraiya and Yoon, Heeyong and Seiler, Christoph and Osei-Frimpong, Bruce and He, Jie and Nair, Rohini M and Mathew, Neal D and Burg, Leonard and Kose, Melis and Venkata, Chavali R M and Anderson, Vernon E and Nakamaru-Ogiso, Eiko and Falk, Marni J},
  title = {N -acetylcysteine and cysteamine bitartrate prevent azide-induced neuromuscular decompensation by restoring glutathione balance in two novel surf1 −/− zebrafish deletion models of Leigh syndrome},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddad031}
}
Kostenlos starten →